GI Tolerance and Acceptability of a New Thickener

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Gastro-intestinal Tolerance Clinical Trial

Official title:
A Study to Evaluate the GI Tolerance and Acceptability of a New Thickener for Dysphagia Patients

Status Withdrawn

Clinical Trial Summary

The current study is designed to evaluate the gastrointestinal tolerance and acceptability of a new thickener for dysphagia patients.

n/a

See also
Status	Clinical Trial	Phase
Completed	`NCT03293706` - Evaluation of Carbohydrates Part 2	N/A
Completed	`NCT01781624` - Evaluation of an Oral Nutritional Supplement	N/A
Completed	`NCT01782456` - Tolerance of an Oral Nutritional Supplement(ONS)	N/A
Completed	`NCT04259437` - Gastrointestinal Tolerance of a Nutritional Supplement in Adult Patients With or at Risk of Malnutrition	N/A
Completed	`NCT03967132` - Growth and Tolerance of Infants Fed Milk-Based Infant Formula	N/A
Terminated	`NCT04934397` - Term Infants Fed a Partially Hydrolyzed Whey Protein-Based Formula	N/A
Completed	`NCT04915937` - Formula Tolerance of Term Infants	N/A